Used as a key intermediate in the synthesis of antidiabetic drugs, particularly in the production of DPP-4 inhibitors like linagliptin. Its chiral structure enables selective interaction with biological targets, enhancing drug efficacy and reducing side effects. Commonly employed in pharmaceutical research and development for optimizing metabolic stability and pharmacokinetic properties in new drug candidates.